Clinical trial CA209-8RX
A national, prospective, Therapeutic Non-Interventional Clinical Trial (TNICT) in patients receiving adjuvant nivolumab therapy for resected melanoma
Cancers | |
---|---|
Organ | Skin |
Trial status | Trial open for recruitment |
Investigator | |
Trial type |
Prospective observational study
|
Phase | Trial phase 4 |
Academic trial | Non |
Sponsor | BMS - Bristol Myers Squibb int. |
BECT Identifier | B143201837780 |
ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT03771859 |
Inclusion criteria | Complete resection |
Last update |